RBP4 and Alzheimer disease: Thus, the overexpression of STRA6 along with the upregulated RBP4 levels in the brain and downregulated CRBP1 on the intracellular side of the receptor might jointly interrupt movement of retinol into cells and dysregulate metabolism in AD.